These promising results with ICRs have led to further ICR investigations, such as the novel IL-4 vs. IL-21 ICR (4/21) that promotes Th17-like polarization in CAR T-cells in response to IL-4 in the TME that resulted in improved tumor-clearance in vivo (117). The gene discussed is IL4; the disease is neoplasm.